3-iodobenzylguanidine has been researched along with Left Ventricular Dysfunction in 95 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (12.63) | 18.2507 |
| 2000's | 51 (53.68) | 29.6817 |
| 2010's | 29 (30.53) | 24.3611 |
| 2020's | 3 (3.16) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda, I; Iwasaki, Y; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Nakamura, J; Ozaki, T; Sato, Y; Seo, M; Tamaki, S; Yamada, T; Yamamoto, H | 1 |
| Koyanagawa, K; Manabe, O; Naya, M; Oyama-Manabe, N; Tamaki, N | 1 |
| Amano, M; Enomoto, S; Harita, T; Himura, Y; Izumi, C; Kondo, H; Kuroda, M; Miyake, M; Nakagawa, Y; Nishimura, S; Nishiuchi, S; Sakamoto, J; Tamaki, Y; Tamura, T | 1 |
| Hashimoto, H; Hashimoto, Y; Ikeda, T; Mizumura, S; Nakanishi, R; Okamura, Y; Yamanaka, K; Yamazaki, J | 1 |
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda-Yorifuji, I; Iwasaki, Y; Kawai, T; Kawasaki, M; Kikuchi, A; Morita, T; Nakamura, J; Seo, M; Tamaki, S; Yamada, T | 1 |
| Ideguchi, T; Ishikawa, T; Kitamura, K; Koyama, S; Nagamachi, S; Onitsuka, H | 1 |
| Cuocolo, A; Gaudieri, V; Giugliano, G; Imbriaco, M; Nappi, C; Pisani, A; Riccio, E; Spinelli, L; Trimarco, B | 1 |
| Carnagarin, R; Chan, JJS; Dwivedi, G; Ho, JK; Kiuchi, MG; Lugo-Gavidia, LM; Matthews, VB; Nolde, JM; Schlaich, MP; Villacorta, H | 1 |
| Hayashi, H; Horie, M; Mitsunami, K; Nakae, I | 1 |
| Al Badarin, F; Bateman, TM; Heller, GV; Jacobson, AF; Parker, M; Pullatt, R; Sood, N | 1 |
| Aggarwal, H; Ahmed, A; Chen, J; Hage, FG; Heo, J; Iskandrian, AE; Jacobson, AF; Patel, K | 1 |
| Genovesi, D; Gimelli, A; Giorgetti, A; Kusch, A; Liga, R; Marzullo, P | 1 |
| Cozar-Santiago, P; Estornell-Erill, J; Fabregat-Andrés, O; García-González, P; Ridocci-Soriano, F; Sánchez-Jurado, R | 1 |
| Harris, D; Soman, P; Wong, TC | 1 |
| Butler, J; Chen, J; Clements, IP; Folks, RD; Garcia, EV; Jacobson, AF | 1 |
| Fukunami, M; Furukawa, Y; Hakui, H; Ishimi, M; Iwasaki, Y; Kawai, T; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Ozaki, T; Sakata, Y; Sato, Y; Seo, M; Takahashi, S; Tamaki, S; Yamada, T | 1 |
| Bevilacqua, A; Cuocolo, A; de Lucia, C; Femminella, GD; Ferrara, N; Ferro, G; Filardi, PP; Formisano, R; Leosco, D; Pagano, G; Paolillo, S; Parisi, V; Pellegrino, T; Prastaro, M; Rengo, G | 1 |
| Cerqueira, M; Farnum, C; Gold, M; Hendel, R; Narula, J; Shaw, L; Singh, J; Thomas, G; Wazni, O; Wolinsky, D | 1 |
| Aragon, DC; da Rocha, ET; da Silva, ET; Dos Santos, MJ; Junior, JS; Verberne, HJ | 1 |
| Cerqueira, MD; Hachamovitch, R; Menon, V; Nutter, B | 1 |
| Goldberger, JJ; Hendel, RC | 1 |
| Doi, T; Hashimoto, A; Nakata, T; Yuda, S | 1 |
| Fukunami, M; Hori, M; Iwasaki, Y; Masuda, M; Morita, T; Okuda, K; Okuyama, Y; Sanada, S; Tamaki, S; Tsukamoto, Y; Yamada, T; Yasui, T | 1 |
| Azevedo, JC; Felix, RC; Mesquita, CT; Mesquita, ET; Nardi, AE; Soares-Filho, GL; Valença, AM | 1 |
| Despas, F; Galinier, M; Guerriero, E; Pathak, A; Senard, J | 1 |
| Agostini, D; Cerqueira, MD; Chandna, H; Jacobson, AF; Lopez, VA; Narula, J; Senior, R; Thomas, GS; Weiland, F; Wong, ND | 1 |
| Aoki, H; Chen, WP; Kajinami, K; Kinuya, S; Matsunari, I; Nakajima, K; Nekolla, SG; Nomura, Y; Takeda, N; Taki, J | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Sato, Y; Sumino, H; Takayama, Y; Toyama, T | 1 |
| Ascaso, JF; Carmena, R; Civera, M; Molina, M; Navarro, I; Real, JT | 1 |
| Hagiwara, N; Kondo, C; Momose, M; Nagamatsu, H; Okayama, D; Sakai, S | 1 |
| Fujiwara, S; Fukuda, Y; Hirata, K; Kaneko, A; Kawai, H; Matsumoto, K; Ryo, K; Shigeru, M; Tanaka, H; Tatsumi, K; Tsuji, T; Yoshida, A | 1 |
| Kelesidis, I; Travin, MI | 1 |
| Beller, GA; Janardhanan, R | 1 |
| Hazama, M; Mori, H; Moriya, M; Suzuki, N; Yano, K | 1 |
| Fukuyama, T; Imamura, Y | 1 |
| Inoue, T; Ishikawa, T; Kimura, K; Kobayashi, T; Matsushita, K; Ohkusu, Y; Oka, T; Sumita, S; Takahashi, N; Uchino, K; Umemura, S; Yamakawa, Y | 1 |
| Fukuda, N; Onose, Y; Sakabe, K; Shinohara, H; Soeki, T; Tamura, Y | 1 |
| Adachi, Y; Azuma, A; Doue, T; Ito, K; Katoh, S; Nakagawa, M; Sugihara, H; Tanabe, T; Yuba, T | 1 |
| Hashimoto, A; Kyuma, M; Nakata, T; Ogata, H; Shimamoto, K; Takahashi, T; Tsuchihashi, K; Wakabayashi, T | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 2 |
| Fujita, M; Fukatsu, Y; Miwa, Y; Okada, T; Shima, T; Shimizu, M; Takahashi, H; Tatsumi, K | 1 |
| Isobe, M; Iwama, T; Kawabata, M; Kubo, I; Suzuki, K; Terai, T | 1 |
| Acar, P; Maunoury, C; Sidi, D | 1 |
| Azizoglu, F; Gökçora, N; Karabacak, NI; Kula, S; Olguntürk, R; Tunaoglu, FS; Turan, L | 1 |
| Adachi, H; Hoshizaki, H; Isobe, N; Naito, S; Oshima, S; Seki, R; Taniguchi, K; Toyama, T | 1 |
| Ino, H; Kawano, M; Mabuchi, H; Nakajima, K; Oe, K; Shimizu, M; Taki, J; Terai, H; Uchiyama, K; Yamaguchi, M | 1 |
| Hirosaka, A; Ishihata, T; Komatsu, N; Maehara, K; Maruyama, Y; Onuki, N; Otani, H; Saito, T; Sato, M; Yaoita, H | 1 |
| Ichikawa, S; Ishikawa, T; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Akashi, YJ; Miyake, F; Musha, H; Nakazawa, K; Sakakibara, M; Sasaka, K | 1 |
| Hamada, M; Hara, Y; Hiasa, G; Ogimoto, A; Ohtsuka, T; Saeki, H; Shigematsu, Y | 1 |
| Kyuma, M; Nakata, T; Shimamoto, K; Takahashi, T; Tsuchihashi, K; Wakabayashi, T | 1 |
| Hosokawa, N; Kamiishi, T; Komura, M; Konagai, H; Miyazaki, S; Sagai, H; Takamoto, T | 1 |
| Hatada, K; Hikosaka, M; Iwasaka, T; Iwasaki, M; Kawamura, A; Mimura, J; Motohiro, M; Sugiura, T; Yuasa, F; Yuyama, R | 1 |
| Imamura, M; Kubo, N; Mabuchi, M; Morita, K; Noriyasu, K; Tamaki, N; Tsukamoto, T; Yasuda, K | 1 |
| Fujino, N; Fujita, T; Funada, A; Ikeda, H; Ino, H; Kaneda, T; Kato, H; Konno, T; Mabuchi, H; Mabuchi, T; Masuda, E; Shimizu, M; Terai, H; Uchiyama, K | 1 |
| Fujiita, T; Horita, Y; Kaku, B; Kanaya, H; Mabuchi, H; Ohka, T; Sakata, K; Shimizu, M; Uno, Y; Yamazaki, T | 1 |
| Azuma, A; Ito, K; Kinoshita, N; Matsubara, H; Sugihara, H | 1 |
| Banki, NM; Dae, MW; Drew, BJ; Foster, E; Kopelnik, A; Lawton, MT; Miss, J; Parmley, WW; Smith, W; Tung, P; Zaroff, JG | 1 |
| Bocchi, EA; Chizzola, PR; Gonçalves de Freitas, HF; Mansur, JA; Marinho, NV; Meneghetti, JC | 1 |
| Fujimoto, M; Hasegawa, M; Kawano, M; Nakajima, K; Takehara, K; Taki, J; Tonami, N | 1 |
| Cobbe, SM; Martin, W; Motherwell, DW; Petrie, MC | 1 |
| Carvalho, PA; da Fonseca, BL; de Almeida, AS; Gutfilen, B; Lima, SL; Mansur, J; Pessoa, PM; Xavier, SS | 1 |
| Bossi, I; De Chiara, B; Mauri, F; Moreo, A; Nicolosi, E; Orrego, PS; Parodi, O; Possa, M; Sara, R | 1 |
| Agostini, D; Habraken, JB; Jacobson, AF; van Eck-Smit, BL; Verberne, HJ | 1 |
| Inubushi, M; Katoh, C; Kuge, Y; Morita, K; Naya, M; Nishijima, K; Okamoto, H; Tamaki, N; Tsukamoto, T; Tsutsui, H | 1 |
| Dimski, T; Heinen-Lauten, J; Krep, H | 1 |
| Agostini, D; Banerjee, G; Burchert, W; Estorch, M; Jacobson, AF; Knuuti, J; Povinec, P; Sambuceti, G; Unlu, M; Verberne, HJ | 1 |
| Hashimoto, A; Kyuma, M; Nagahara, D; Nakata, T; Noda, R; Shimamoto, K; Shimoshige, S; Tsuchihashi, K; Uno, K; Wakabayashi, T | 1 |
| Bax, JJ; Boogers, M; Henneman, MM | 1 |
| Asirvatham, SJ; Cha, YM; Chareonthaitawee, P; Chen, PS; Hayes, DL; Hodge, DO; Kemp, BJ; Miyazaki, C; Oh, J; Rea, RF; Shen, WK | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Nakazawa, M; Sato, Y; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Ishikawa, A; Ishizuka, T; Kurata, C; Okayama, K; Sakamoto, S; Shouda, S; Suzuki, K; Tawarahara, K; Wakabayashi, Y; Yamamoto, T | 1 |
| Gen, H; Himura, Y; Iga, K; Izumi, C; Kijima, K; Konishi, T; Miyamoto, T | 1 |
| Asano, R; Horie, T; Hosoda, S; Kashikura, K; Kobayashi, H; Kusakabe, K; Matsumoto, N; Momose, M; Saitou, K | 1 |
| Ando, S; Egashira, K; Koyanagi, S; Kubota, T; Kuroiwa-Matsumoto, M; Kuwabara, Y; Sasaki, M; Takeshita, A; Tsutsui, H; Yasui, H | 1 |
| Hayano, T; Iwami, T; Kume, N; Matsunaga, N; Nishigauchi, K; Suga, K; Tsukamoto, K | 1 |
| Fukuoka, S; Hamada, S; Hayashida, K; Hirose, Y; Ishida, Y; Kawano, S; Kuribayashi, S; Maeno, M; Ohe, T; Shimomura, K; Takahashi, N; Takamiya, M; Yamada, N | 1 |
| Batink, HD; Brandsma, K; de Jong, J; Dubois, EA; Lie, KI; Somsen, GA; van der Wouw, PA; van Royen, EA; van Zwieten, PA | 1 |
| Adachi, K; Araki, S; Ikoma, T; Kawata, M; Matsumoto, A; Mukai, T | 1 |
| Endo, K; Iizuka, T; Inoue, T; Kato, N; Kubota, S; Nagai, R; Nagaoka, H; Suzuki, T | 1 |
| Avogaro, A; Casara, D; Crepaldi, C; Dalla Volta, S; Erle, G; Fasoli, G; Marin, M; Mingardi, R; Palisi, M; Scognamiglio, R | 1 |
| Juillière, Y; Marie, PY | 1 |
| Ishida, Y; Kyotani, S; Nagaya, N; Nakanishi, N; Sakamaki, F; Satoh, T | 1 |
| Abe, S; Haida, M; Handa, S; Kozuma, R; Shinohara, Y; Yoshii, F; Yoshitake, M | 1 |
| Ishida, Y; Kuribayashi, S; Kyotani, S; Nagaya, N; Nakanishi, N; Oya, H; Sakamaki, F; Satoh, T | 1 |
| Antloga, CM; Bromberg-Marin, G; Maciel, BC; Marin-Neto, JA; Pazin-Filho, A; Pintya, AO; Sarabanda, AV; Simões, MV | 1 |
| Maehira, N; Sadamatsu, K; Tashiro, H; Yamamoto, K | 1 |
| Avogaro, A; Casara, D; Scognamiglio, R | 1 |
| Fukuyama, T; Imamura, Y; Miyagawa, M; Mochizuki, T; Watanabe, K | 1 |
| Aizawa, K; Ichinose, H; Ikeda, S; Kagoshima, M; Karasawa, K; Koyama, J; Owa, M; Urasawa, N; Yamamoto, K | 1 |
| Asai, M; Asano, Y; Fukunami, M; Hirata, A; Hoki, N; Hori, M; Kumagai, K; Kusuoka, H; Ogita, H; Shimonagata, T; Yamada, T | 1 |
| Akashi, YJ; Miyake, F; Sakakibara, M | 1 |
| Hayashi, K; Ino, H; Mabuchi, H; Nakajima, K; Shimizu, M; Taki, J; Terai, H; Yamaguchi, M | 1 |
| Ando, M; Kawai, H; Sakurai, K; Yamabe, H; Yokoyama, M | 1 |
6 review(s) available for 3-iodobenzylguanidine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
The role of multimodality imaging in takotsubo cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Cardiology; Cardiovascular Diseases; Echocardiography; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Magnetic Resonance Spectroscopy; Multimodal Imaging; Nuclear Medicine; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Takotsubo Cardiomyopathy; Ventricular Dysfunction, Left | 2019 |
New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
Topics: 3-Iodobenzylguanidine; Animals; Arrhythmias, Cardiac; Catecholamines; Death, Sudden, Cardiac; Disease Models, Animal; Ephedrine; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Sympathetic Nervous System; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
[Catecholamine-induced cardiomyopathy triggered by pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Adrenal Gland Neoplasms; Adrenalectomy; Catecholamines; Combined Modality Therapy; Diagnosis, Differential; Dyslipidemias; Female; Humans; Hypertension; Metanephrine; Middle Aged; Myocardial Infarction; Phenoxybenzamine; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Vanilmandelic Acid; Ventricular Dysfunction, Left | 2011 |
Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Humans; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2012 |
Radionuclide imaging in stage B heart failure.
Topics: 3-Iodobenzylguanidine; Asymptomatic Diseases; Cardiomyopathies; Chronic Disease; Coronary Artery Disease; Glucose; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Prognosis; Radionuclide Ventriculography; Radiopharmaceuticals; Sarcoidosis; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2012 |
[Isotopes and idiopathic dilated cardiomyopathy].
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Dilated; Gallium Radioisotopes; Humans; Prognosis; Radiography; Radionuclide Ventriculography; Radiopharmaceuticals; Thallium Radioisotopes; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 1998 |
20 trial(s) available for 3-iodobenzylguanidine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
The relationship of left ventricular mechanical dyssynchrony and cardiac sympathetic denervation to potential sudden cardiac death events in systolic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Cohort Studies; Death, Sudden, Cardiac; Female; Follow-Up Studies; Heart; Heart Failure, Systolic; Heart Ventricles; Humans; Male; Middle Aged; Neurons; Perfusion; Prognosis; Software; Sympathetic Nervous System; Technetium; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2014 |
Effect of left ventricular dyssynchrony on cardiac sympathetic activity in heart failure patients with wide QRS duration.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Resynchronization Therapy; Echocardiography; Electrocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy--importance of background correction for quantification of MIBG activity.
Topics: 3-Iodobenzylguanidine; Artifacts; Cardiomyopathy, Dilated; Female; Follow-Up Studies; Humans; Image Enhancement; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Ventricular Dysfunction, Left | 2002 |
Anti-tachycardia therapy can improve altered cardiac adrenergic function in tachycardia-induced cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Cardiomyopathy, Dilated; Diagnosis, Differential; Echocardiography; Female; Humans; Male; Mediastinum; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stroke Volume; Systole; Tachycardia; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Tetrazoles; Treatment Outcome; Ultrasonography; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenergic alpha-Antagonists; Adrenergic Fibers; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Child; Child, Preschool; Female; Gated Blood-Pool Imaging; Humans; Infant; Male; Propanolamines; Radiopharmaceuticals; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
Topics: 3-Iodobenzylguanidine; Adrenergic Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart Ventricles; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Technetium Tc 99m Sestamibi; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cardiomyopathy, Hypertrophic; Female; Heart Ventricles; Humans; Male; Metabolic Clearance Rate; Middle Aged; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2003 |
Correlation between cardiac norepinephrine overflow during exercise and cardiac 123I-MIBG uptake in patients with chronic heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Chronic Disease; Exercise Test; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Rest; Statistics as Topic; Ventricular Dysfunction, Left | 2003 |
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dopamine; Drug Combinations; Female; Furosemide; Heart; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
123I-MIBG myocardial scintigraphy in patients with "takotsubo" cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathies; Female; Humans; Male; Myocardial Stunning; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Syndrome; Ventricular Dysfunction, Left | 2004 |
Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; Drug Combinations; Female; Heart Failure; Humans; Japan; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction.
Topics: 3-Iodobenzylguanidine; Angioplasty, Balloon, Coronary; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nicorandil; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2005 |
Sympathetic denervation and reinnervation after the maze procedure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cardiac Surgical Procedures; Denervation; Female; Heart; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Nerve Regeneration; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Assessment of Takotsubo cardiomyopathy (transient left ventricular apical ballooning) using 99mTc-tetrofosmin, 123I-BMIPP, 123I-MIBG and 99mTc-PYP myocardial SPECT.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Cardiomyopathies; Diagnosis, Differential; Fatty Acids; Female; Humans; Iodobenzenes; Male; Middle Aged; Myocardial Infarction; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Syndrome; Technetium Tc 99m Pyrophosphate; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Double-Blind Method; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Selection; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Cardiac resynchronization therapy upregulates cardiac autonomic control.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System; Defibrillators, Implantable; Electrocardiography, Ambulatory; Feedback; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2008 |
Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Analysis of Variance; Chagas Cardiomyopathy; Female; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Probability; Radionuclide Imaging; Reference Values; Regional Blood Flow; Sensitivity and Specificity; Statistics, Nonparametric; Sympathectomy; Sympathetic Nervous System; Thallium Radioisotopes; Ventricular Dysfunction, Left | 2000 |
Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiomyopathies; Death; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
69 other study(ies) available for 3-iodobenzylguanidine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Prospective Studies; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
Very long-term follow-up data of non-ischemic idiopathic dilated cardiomyopathy after beta-blocker therapy: recurrence of left ventricular dysfunction and predictive value of
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Cardiomyopathy, Dilated; Female; Follow-Up Studies; Forecasting; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
Prognostic values of
Topics: 3-Iodobenzylguanidine; Aged; Echocardiography; Female; Heart Failure; Heart Rate; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Stroke Volume; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2020 |
Prediction of sudden cardiac death in chronic heart failure patients with reduced ejection fraction by ADMIRE-HF risk score and early repolarization pattern.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Electrocardiography; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardium; Prevalence; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk; Risk Assessment; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2020 |
Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.
Topics: 3-Iodobenzylguanidine; Aged; Biological Availability; Dose-Response Relationship, Drug; Female; Furosemide; Heart; Heart Failure; Humans; Japan; Male; Middle Aged; Myocardial Perfusion Imaging; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2019 |
Focal reduction in left ventricular
Topics: 3-Iodobenzylguanidine; Adult; Fabry Disease; Female; Heart Ventricles; Humans; Male; Middle Aged; Radiopharmaceuticals; Sympathetic Nervous System; Systole; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Young Adult | 2021 |
Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases.
Topics: 3-Iodobenzylguanidine; Aged; Biological Transport; Diagnosis, Differential; Female; Heart Diseases; Humans; Lewy Body Disease; Lung; Male; Middle Aged; Parkinson Disease; Prognosis; Radionuclide Imaging; Survival Analysis; Ventricular Dysfunction, Left | 2013 |
Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Analysis of Variance; Arrhythmias, Cardiac; Cardiomyopathies; Clinical Trials as Topic; Cohort Studies; Female; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Perfusion; Prospective Studies; Regression Analysis; Risk; Sympathetic Nervous System; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2013 |
Association between left ventricular regional sympathetic denervation and mechanical dyssynchrony in phase analysis: a cardiac CZT study.
Topics: 3-Iodobenzylguanidine; Aged; Cadmium; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Female; Gamma Cameras; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Stroke Volume; Sympathetic Fibers, Postganglionic; Tellurium; Ventricular Dysfunction, Left; Zinc | 2014 |
Evaluation of cardiac (123)I-MIBG imaging in patients with severe left ventricular dysfunction and indication for implantable cardioverter defibrillator.
Topics: 3-Iodobenzylguanidine; Aged; Defibrillators, Implantable; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Radionuclide Imaging; Sampling Studies; Severity of Illness Index; Spain; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 2013 |
Direct visualization of regional cardiac sympathetic dysfunction in stress-induced cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Cardiomyopathies; Diagnosis, Differential; Exercise Test; Female; Humans; Magnetic Resonance Angiography; Middle Aged; Tomography, Emission-Computed, Single-Photon; User-Computer Interface; Ventricular Dysfunction, Left | 2015 |
Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Heart Failure; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Machine Learning; Male; Middle Aged; Multimodal Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2016 |
Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
Topics: 3-Iodobenzylguanidine; Chronic Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk; Ventricular Dysfunction, Left | 2015 |
Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Echocardiography, Three-Dimensional; Female; Heart Failure; Humans; Male; Middle Aged; Multimodal Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2015 |
The Role of I-123 Metaiodobenzylguanidine Imaging in Management of Patients With Heart Failure.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Consensus; Death, Sudden, Cardiac; Defibrillators, Implantable; Disease Management; Heart; Heart Failure; Heart-Assist Devices; Humans; Iodine Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2015 |
Assessment of late anthracycline-induced cardiotoxicity by
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Autonomic Nervous System Diseases; Brazil; Cardiotoxicity; Causality; Child; Child, Preschool; Comorbidity; Female; Humans; Male; Neoplasms; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2017 |
Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
Topics: 3-Iodobenzylguanidine; Aged; Chi-Square Distribution; Decision Support Techniques; Defibrillators, Implantable; Disease-Free Survival; Electric Countershock; Europe; Female; Heart Failure; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Nonlinear Dynamics; North America; Patient Selection; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Systole; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Decision Making for Implantable Cardioverter Defibrillator Implantation: Is There a Role for Neurohumoral Imaging?
Topics: 3-Iodobenzylguanidine; Decision Support Techniques; Defibrillators, Implantable; Electric Countershock; Female; Heart Failure; Humans; Male; Radiopharmaceuticals; Systole; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Output, Low; Death, Sudden, Cardiac; Electrocardiography; Female; Heart Conduction System; Heart Failure; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2018 |
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with si
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Female; Heart Failure, Systolic; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2009 |
Broken heart or takotsubo syndrome: support for the neurohumoral hypothesis of stress cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Echocardiography; Female; Humans; Myocardial Perfusion Imaging; Radiography; Radiopharmaceuticals; Takotsubo Cardiomyopathy; Ventricular Dysfunction, Left | 2010 |
Limited prognostic value of cardiac metaiodobenzylguanidine in advanced heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Cause of Death; Disease-Free Survival; Exercise Test; Female; Heart; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Patient Selection; Prospective Studies; Radionuclide Imaging; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2010 |
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
Topics: 3-Iodobenzylguanidine; Aged; Disease Progression; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Research Design; Risk Assessment; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2010 |
Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Ephedrine; Female; Heart; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Stroke Volume; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Death, Sudden, Cardiac; Female; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2011 |
Long-term prognostic stratification by a combination of (123)I-metaiodobenzylguanidine scintigraphy and ejection fraction in dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Dilated; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Radionuclide Imaging; Stroke Volume; Survival Analysis; Time Factors; Ventricular Dysfunction, Left | 2011 |
Six-month follow-up of takotsubo cardiomyopathy with I-123-beta-metyl-iodophenyl pentadecanoic acid and I-123-meta-iodobenzyl-guanidine myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathies; Electrocardiography; Fatty Acids; Heart; Heart Ventricles; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2002 |
Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Creatinine; Echocardiography; Female; Heart; Heart Failure; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Potassium; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Angiotensin; Renin; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
[A case of "Takotsubo" cardiomyopathy observed with myocardial scintigraphy from the acute phase].
Topics: 3-Iodobenzylguanidine; Acute-Phase Reaction; Cardiomyopathies; Coronary Vasospasm; Fatty Acids; Female; Gated Blood-Pool Imaging; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Microcirculation; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction.
Topics: 3-Iodobenzylguanidine; Diabetes Mellitus; Female; Follow-Up Studies; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Time Factors; Ventricular Dysfunction, Left | 2003 |
[Reversible left ventricular dysfunction manifesting as hyperkinesis of the basal and the apical areas with akinesis of the mid portion: a case report].
Topics: 3-Iodobenzylguanidine; Coronary Vasospasm; Echocardiography; Electrocardiography; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Radionuclide Ventriculography; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2003 |
'Tako-Tsubo cardiomyopathy' associated with syndrome malin: reversible left ventricular dysfunction.
Topics: 3-Iodobenzylguanidine; Aged; Amantadine; Antidepressive Agents, Tricyclic; Cardiomyopathies; Coronary Angiography; Humans; Imipramine; Male; Neuroleptic Malignant Syndrome; Radionuclide Imaging; Radiopharmaceuticals; Recovery of Function; Thallium Radioisotopes; Ventricular Dysfunction, Left | 2003 |
Abnormality of the left ventricular sympathetic nervous function assessed by I-123 metaiodobenzylguanidine imaging in pediatric patients with neurocardiogenic syncope.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Female; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Syncope, Vasovagal; Tilt-Table Test; Ventricular Dysfunction, Left | 2003 |
Cardiac sympathetic nerve activity can detect congestive heart failure sensitively in patients with hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Volume; Cardiomyopathies; Early Diagnosis; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2004 |
Reversible left ventricular dysfunction "takotsubo" cardiomyopathy associated with hyperthyroidism.
Topics: 3-Iodobenzylguanidine; Aged; Coronary Angiography; Echocardiography; Electrocardiography; Female; Heart; Humans; Hyperthyroidism; Iodine Radioisotopes; Myocardial Stunning; Radionuclide Imaging; Technetium Tc 99m Pyrophosphate; Ventricular Dysfunction, Left | 2004 |
Iodine 123-metaiodobenzylguanidine imaging reflect generalized sympathetic activation in patients with left ventricular dysfunction.
Topics: 3-Iodobenzylguanidine; Electrocardiography; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Radiopharmaceuticals; Severity of Illness Index; Sympathetic Nervous System; Time Factors; Tomography, Emission-Computed; Ultrasonography; Ventricular Dysfunction, Left | 2005 |
Images in cardiovascular medicine. Adult patient with isolated noncompaction of ventricular myocardium.
Topics: 3-Iodobenzylguanidine; Autopsy; Fatal Outcome; Female; Heart Failure; Heart Ventricles; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 2005 |
Abnormal sympathetic innervation of the heart in a patient with Emery-Dreifuss muscular dystrophy.
Topics: 3-Iodobenzylguanidine; Adult; Heart; Heart Defects, Congenital; Humans; Male; Muscular Dystrophy, Emery-Dreifuss; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2005 |
Acute neurocardiogenic injury after subarachnoid hemorrhage.
Topics: 3-Iodobenzylguanidine; Acute Disease; Adult; Aged; Echocardiography; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Norepinephrine; Prospective Studies; Radionuclide Imaging; Subarachnoid Hemorrhage; Sympathetic Nervous System; Technetium Tc 99m Sestamibi; Troponin I; Ventricular Dysfunction, Left | 2005 |
Myocardial damages in systemic sclerosis detected by gated myocardial perfusion SPECT and sympathetic imaging.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Diastole; Female; Heart; Heart Diseases; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Scleroderma, Systemic; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2006 |
123I- Metaiodobenzylguanidine in chronic heart failure: Is there a clinical use?
Topics: 3-Iodobenzylguanidine; Chronic Disease; Heart Failure; Humans; Metabolic Clearance Rate; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2006 |
Assessment of takotsubo (ampulla) cardiomyopathy using iodine-123 metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathies; Citrates; Coronary Angiography; Echocardiography; Female; Gallium; Humans; Middle Aged; Myocardial Stunning; Radiopharmaceuticals; Sensitivity and Specificity; Syndrome; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2006 |
Functional derangement and cardiac innervation in the apical ballooning syndrome: a 123I-meta-iodobenzylguanidine scintigraphic and dobutamine stress echocardiographic study.
Topics: 3-Iodobenzylguanidine; Aged; Coronary Angiography; Echocardiography, Stress; Electrocardiography; Female; Humans; Myocardial Reperfusion; Radionuclide Imaging; Radiopharmaceuticals; Syndrome; Ventricular Dysfunction, Left | 2007 |
Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Coronary Artery Disease; Europe; Heart; Heart Failure; Humans; Mediastinum; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Carbon Radioisotopes; Cardiomyopathies; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Presynaptic Terminals; Propanolamines; Radiopharmaceuticals; Receptors, Adrenergic, beta; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2007 |
[Basal tako-tsubo cardiomyopathy. Induction of a pheochromocytoma after general anesthesia].
Topics: 3-Iodobenzylguanidine; Aged; Anesthesia, General; Cataract Extraction; Electrocardiography; Female; Heart Failure; Humans; Pheochromocytoma; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Takotsubo Cardiomyopathy; Ultrasonography; Ventricular Dysfunction, Left | 2008 |
I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Europe; Heart; Heart Failure; Humans; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?
Topics: 3-Iodobenzylguanidine; Coronary Artery Disease; Heart; Heart Failure; Humans; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Ventricular Dysfunction, Left | 2008 |
Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Comorbidity; Female; Heart Failure; Humans; Incidence; Japan; Male; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume; Survival Analysis; Survival Rate; Ventricular Dysfunction, Left | 2008 |
Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure.
Topics: 3-Iodobenzylguanidine; Adult; Case-Control Studies; Echocardiography; Female; Heart; Humans; Hypertrophy, Left Ventricular; Iodine Radioisotopes; Iodobenzenes; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Norepinephrine; Radionuclide Imaging; Renal Dialysis; Sympatholytics; Ventricular Dysfunction, Left | 1995 |
Reversible left ventricular dysfunction associated with Guillain-Barré syndrome--an expression of catecholamine cardiotoxicity?
Topics: 3-Iodobenzylguanidine; Aged; Catecholamines; Female; Follow-Up Studies; Humans; Iodobenzenes; Nerve Endings; Polyradiculoneuropathy; Sympathetic Nervous System; Ventricular Dysfunction, Left | 1995 |
[Initial myocardial uptake and myocardial clearance of 123I-metaiodobenzylguanidine in patients with ischemic heart disease of left ventricular dysfunction and dilated cardiomyopathy].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cardiomyopathy, Dilated; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Ischemia; Radionuclide Imaging; Ventricular Dysfunction, Left; Ventricular Function, Left | 1994 |
Abnormalities of cardiac sympathetic neuronal and left ventricular function in chronic mitral regurgitation: assessment by iodine-123 metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Cardiac Catheterization; Case-Control Studies; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitral Valve Insufficiency; Myocardial Contraction; Sympathetic Nervous System; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1996 |
Iodine-123-MIBG imaging in pheochromocytoma with cardiomyopathy and pulmonary edema.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Cardiomyopathies; Contrast Media; Epinephrine; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Norepinephrine; Pheochromocytoma; Pulmonary Edema; Radionuclide Imaging; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Ultrasonography; Ventricular Dysfunction, Left | 1996 |
[Significance of 123I-metaiodobenzylguanidine SPECT for detecting left ventricular involvement in patients with arrhythmogenic right ventricular dysplasia].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Heart; Humans; Hypertrophy, Left Ventricular; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Tachycardia, Ventricular; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 1996 |
Cardiac sympathetic neuronal function in left ventricular volume and pressure overload.
Topics: 3-Iodobenzylguanidine; Animals; Down-Regulation; Heart; Heart Failure; Heart Ventricles; Iodobenzenes; Male; Norepinephrine; Rabbits; Receptors, Adrenergic, beta; Sympathetic Nervous System; Sympatholytics; Ventricular Dysfunction, Left | 1996 |
A case of Crush syndrome with giant negative T waves and reversible left ventricular dysfunction.
Topics: 3-Iodobenzylguanidine; Crush Syndrome; Disasters; Echocardiography; Electrocardiography; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1996 |
Depressed contractile response to exercise in diabetic patients in the absence of cardiovascular disease: relationship to adrenergic cardiac dysinnervation.
Topics: 3-Iodobenzylguanidine; Biological Transport; Diabetes Mellitus, Type 2; Exercise Test; Female; Humans; Japan; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Radionuclide Angiography; Radiopharmaceuticals; Reference Values; Sympatholytics; Thallium Radioisotopes; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |
Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Agonists; Adrenergic Fibers; Adult; Body Weight; Cardiac Complexes, Premature; Cardiac Output, Low; Cardiac Volume; Cardiomyopathies; Case-Control Studies; Diabetes Mellitus, Type 1; Dobutamine; Echocardiography; Electric Stimulation; Exercise; Female; Hand Strength; Heart Conduction System; Humans; Incidence; Linear Models; Male; Myocardial Contraction; Physical Exertion; Radionuclide Imaging; Radiopharmaceuticals; Rest; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 1998 |
Abnormality of left ventricular sympathetic nervous function assessed by (123)I-metaiodobenzylguanidine imaging in patients with COPD.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Humans; Iodine Radioisotopes; Lung Diseases, Obstructive; Male; Middle Aged; Norepinephrine; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Function Tests; Sympathetic Nervous System; Ventricular Dysfunction, Left | 1999 |
Giant negative T waves in Guillain-Barré syndrome.
Topics: 3-Iodobenzylguanidine; Aged; Echocardiography; Female; Guillain-Barre Syndrome; Heart; Humans; Median Nerve; Neural Conduction; Peroneal Nerve; Severity of Illness Index; Sympatholytics; Systole; Tibial Nerve; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2000 |
Correlation between severity of pulmonary arterial hypertension and 123I-metaiodobenzylguanidine left ventricular imaging.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cardiac Catheterization; Female; Heart Ventricles; Humans; Hypertension, Pulmonary; Male; Middle Aged; Norepinephrine; Pulmonary Embolism; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Vascular Resistance; Ventricular Dysfunction, Left | 2000 |
Coronary microvascular abnormality in the reversible systolic dysfunction observed after noncardiac disease.
Topics: 3-Iodobenzylguanidine; Acute Disease; Aged; Cerebral Infarction; Diagnosis, Differential; Echocardiography; Electrocardiography; Humans; Inappropriate ADH Syndrome; Male; Microcirculation; Myocardial Stunning; Ventricular Dysfunction, Left | 2000 |
Myocardial dysfunction and adrenergic innervation in patients with Type 1 diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Adult; Cardiac Output; Cardiac Volume; Cardiomyopathies; Cohort Studies; Diabetes Mellitus, Type 1; Echocardiography; Exercise; Female; Hand Strength; Humans; Male; Radionuclide Imaging; Ventricular Dysfunction, Left; Ventricular Function | 2000 |
Emotional stress-induced 'ampulla cardiomyopathy': discrepancy between the metabolic and sympathetic innervation imaging performed during the recovery course.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Catecholamines; Chest Pain; Disasters; Emotions; Family Relations; Fatty Acids; Female; Heart; Heart Conduction System; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Myocardium; Nerve Endings; Radiopharmaceuticals; Stress, Psychological; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2001 |
Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Ventricular Dysfunction, Left | 2001 |
Reversible left ventricular dysfunction "takotsubo" cardiomyopathy associated with pneumothorax.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Chest Pain; Dyspnea; Electrocardiography; Female; Follow-Up Studies; Humans; Magnetic Resonance Angiography; Pneumothorax; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2002 |
Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Hypertrophic; Case-Control Studies; Echocardiography; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Contraction; Radiopharmaceuticals; Regression Analysis; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Relationship between cardiac sympathetic function and baroreceptor sensitivity after acute myocardial infarction.
Topics: 3-Iodobenzylguanidine; Aged; Baroreflex; Cohort Studies; Female; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2002 |